Sort
25,944 grants matching “neurodegeneration”
FRIEDRIECHS ATAXIA, MITOCHONDRIA AND CELL DEATH
$225,624University Of California Davis · R01 · FY2002 · AG
Molecular and Physiological Responses to Persistent Mitochondrial DNA Damage
$225,600Joel Newman Meyer · Duke University · R21 · FY2009 · NS
Structure and Function of Neuronal Calcium Binding Proteins (CaBPs)
$225,527James B Ames · University Of California At Davis · R01 · FY2009 · NS
Neuroimaging and Neuropathic Substrates of Cognitive Deficits in Mouse Models of HIV, METH and Aging
$225,304Svetlana Semenova · University Of California, San Diego · P50 · FY2015 · DA
CATECHOL THIOETHERS IN PARKINSON'S DISEASE
$225,177Vanderbilt University · R01 · FY2001 · ES
Saracatinib Mitigates OP nerve agent-induced Long-term Neurotoxicity
$225,140Thimmasettappa Thippeswamy · Iowa State University · R21 · FY2019 · NS
Towards GLIMPSE: Enabling technology to map cytokines in inflamed tissue
$225,135Rebecca R Pompano · University Of Virginia · R21 · FY2021 · AI
CRCNS: The diffusional complexity of the brain's extracellular space
$225,097Fidel Santamaria · University Of Texas San Antonio · R01 · FY2022 · NS
Role of EAAT2 and AEG-1 in Astrocyte Dysfunction and Neurodegeneration
$225,083Paul B Fisher · St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2006 · NS
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions
$225,083David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2006 · NS
The role of mito-nuclear communication in the adaptation to mitochondrial dysfunction and stress resistance
$225,082Alaattin Kaya · Virginia Commonwealth University · R35 · FY2024 · GM
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS
$225,010Massachusetts General Hospital · P50 · FY2005 · AG
Parkin and MGRN1: common roles in mitochondria and neurodegeneration?
$225,000Teresa M Gunn · Mc Laughlin Research Institute · R21 · FY2010 · NS
SBIR Phase I: Engaging the Mind and Body: Technology to Automate Physical Therapy Treatments for Patients with Parkinson's Disease (PD).
$225,000Bennett Gatto · Active Therapy Systems Llc · · FY2018 · TIP
Development of a kit for characterization of cellular energetics in single cells in cell and tissue cultures based on the measurement of the absolute magnitude of the mitochondrial membrane potential
$225,000Akos A Gerencser · Image Analyst Software · R41 · FY2016 · DA
UBIQUITINATED PROTEIN DEGRADATION &NEURODEGENERATION
$225,000Hunter College · R01 · FY2002 · NS
UBIQUITINATED PROTEIN DEGRADATION &NEURODEGENERATION
$225,000Hunter College · R01 · FY2000 · NS
UBIQUITINATED PROTEIN DEGRADATION &NEURODEGENERATION
$225,000Hunter College · R01 · FY2001 · NS
Extracellular alpha-synuclein in Parkinson's Disease
$225,000Pamela J McLean · Mayo Clinic Jacksonville · R01 · FY2011 · NS
Tat and CDK9 on gene expression alterations coupled to HIV-1 Associated Dementia
$225,000Xavier Grana · Temple Univ Of The Commonwealth · R21 · FY2009 · MH
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
$225,000Robert G Lowery · Bellbrook Labs, Llc · R41 · FY2015 · NS
Enzyme Replacement Therapy for GM1 Gangliosidosis Lysosomal Rare Disease
$225,000David Radin · Biostrategies, Lc · R43 · FY2014 · NS
Human Neural Stem Cells for HD: Technical and Empirical Advances
$225,000Jeffrey H Kordower · Rush University Medical Center · R21 · FY2012 · NS
New Targeted BDNF Nanoparticles for Treatment of Dopaminergic Neurodegeneration in METH Addiction and HAND
$225,000Franco Vitaliano · Exqor Technologies, Inc. · R43 · FY2017 · DA
IND, FIH study and 3-month tox for PTI-125, a novel therapeutic for Alzheimer's disease
$225,000Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2017 · AG